Company Data
Aprea Therapeutics Inc.
Ticker
APRE
Current Price
$2.62 -7.75%
Market Cap
$14.2M
Price Target
Refer to Report
Volume
20.2K
52wk Range
$2.1501 - $8.8465
Overview
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).